Open AccessReporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study
Author(s) -
Teresa M. Salgado,
Caroline Quinn,
Emily K Krumbach,
Iris Wenceslao,
Martha M. Gonzalez,
Holly L. Reed,
Jillian G. Syverson,
Rebecca Etz,
Kiran Vangipuram,
Melissa R Barker,
Norah Lynn Henry,
Karen B. Farris,
Daniel L. Hertz
Publication year - 2020
Publication title -
supportive care in cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.133
H-Index - 112
eISSN - 1433-7339
pISSN - 0941-4355
DOI - 10.1007/s00520-019-05254-6
Subject(s) - chemotherapy induced peripheral neuropathy , medicine , discontinuation , nursing research , qualitative research , breast cancer , pain medicine , observational study , peripheral neuropathy , family medicine , oncology , cancer , psychiatry , nursing , social science , anesthesiology , endocrinology , sociology , diabetes mellitus
Cases of chemotherapy-induced peripheral neuropathy (CIPN) under-reporting have been sporadically described in the literature, but no studies have focused on actively examining this behavior. Our primary aim was to identify women who purposefully under-reported CIPN, along with reasons for doing so. A secondary aim was to explore factors enabling or hindering communication of CIPN to clinicians.